News › Industry News, News

FDA Warns Five Firms To Stop Compounding Topical Anesthetic Creams

October 16, 2014

The Food and Drug Administration (FDA) is warning five firms, Triangle
Compounding Pharmacy, University Pharmacy, Custom Scripts Pharmacy,
Hal’s Compounding Pharmacy, and New England Compounding Center, to stop
compounding and distributing standardized versions of topical anesthetic
creams, which are marketed for general distribution rather than
responding to the unique medical needs of individual patients. Firms
that do not resolve violations in FDA warning letters risk enforcement
such as injunctions against continuing violations and seizure of illegal
products. Read more here: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108793.htm

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Medical Marketing Whiz Recognized With Healthcare Digital Marketing Excellence Award
    • Allergan Presents Early Data on Skin Quality Treatments for Patients Taking Weight-Loss Medications
    • ValueCap Becomes Silver Vendor Affiliate with the American Med Spa Association
    • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s
    • Allergan Aesthetics Debuts AA Signature in the United States with SKIN360
Advertisement